Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Analysis of serum biomarkers (BM) in patients (pts) from a phase 3 study of lenvatinib (LEN) vs sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC)Finn, R.S. ; Kudo, M. ; Cheng, A-L. ; Wyrwicz, L. ; Ngan, R. ; Blanc, J-F. ; Baron, A.D. ; Vogel, A. ; Ikeda, M. ; Piscaglia, F. ; Han, K-H. ; Qin, S. ; Minoshima, Y. ; Funahashi, Y. ; Ren, M. ; Dairiki, R. ; Sachdev, P. ; Tamai, T. ; Dutcus, C. ; Evans, T.R.J.Annals of oncology, 2017-09, Vol.28, p.v617-v617 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |